All stocks / YBGJ
Yubo International Biotech Ltd YBGJ
Yubo International Biotech (YBGJ): shares outstanding up 42% in a year and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- YUBO INTL BIOTECH LTD
- Market tier
- OTC Pink Current
- Trading status
- Active
- Last trade
- Nov 13
The financial report, and what it means
Annual figures to 2025-12-31- Revenue
- $12,353
- Net loss
- ($1,079,248)
It spends more than it earns
Under strainCustomers paid it $12,353 in the year. It lost $1.1 million. For every $1 that came in, about $88.37 went out.
- Cash and cash equivalents
- $8,062
- Net cash used in operating activities
- ($842,802)
The cash could run out soon
Under strainIt had $8,062 in the bank and used about $70,234 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.
- Total assets
- $847,094
- Total liabilities
- $2,791,297
It owes more than it owns
Under strainEverything the company owns adds up to $847,094. Its debts and unpaid bills add up to $2.8 million. That is about $3.30 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Shares outstanding rose from 119,816,343 (2025-03-31) to 170,416,343 (2026-03-25), up 42%.
Rule: Shares outstanding up 20% or more in 12 months. Source record
Estimated float about 170,416,343 shares as of 2026-03-25: 170,416,343 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about YBGJ
Does YBGJ file reports with the SEC?
Yes. Yubo International Biotech files with the SEC under company number 0000895464. The most recent filing we hold is a 10-Q dated 2026-11-10.
Source recordHow many YBGJ shares are outstanding?
170,416,343 shares as of 2026-03-25, as reported to the SEC. That is up 42% from 119,816,343 on 2025-03-31.
Source recordHas YBGJ filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Is Yubo International Biotech making money?
Customers paid it $12,353 in the year. It lost $1.1 million. For every $1 that came in, about $88.37 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record